Here at CooperVision we understand how important contact lenses are to people’s daily lives, recognise that every wearer is unique and appreciate the importance of crafting world-class lenses for both mainstream and challenging vision corrections. Our focus goes beyond product development to true innovation, tackling some of the greatest challenges of our time such as myopia management and the impact of the global transformation to a digital lifestyle. CooperVision is also committed to providing focused practitioner support, through partnership activities and our Cooper Advantage™ programme.
Practice of the Year sponsor
Only Optos provides ultra-widefield images of 2000 (82%) of the retina in a single non-contact optomap® image. Our technology provides 3-in-1 Colour Depth Imaging™, including sensory, choroidal and composite colour views, as well as autofluorescence imaging with green laser displaying lipofuscin in the RPE. Early signs of many ocular pathologies and diseases may first present in the retinal periphery and can initially go undetected using traditional examination techniques and equipment, optomap can image past the equator helping you find disease sooner and treat it more effectively. Optos has recently launched Monaco, the first and only ultra-widefield retinal imaging device with integrated OCT. Monaco enables a rapid multi-modal capture featuring colour, autofluorescence and OCT scans for both eyes in as little as 90 seconds.
Lifetime Achievement Award
For more than 70 years, Alcon® has been reimagining eye care together with its customers and their patients. Through innovative products, customer partnerships and education for eye care professionals, Alcon has continued to demonstrate its commitment to eye care excellence and helping people see brilliantly. https://www.alcon.com/
Johnson & Johnson Vision
Locum of the Year
Johnson & Johnson Vision is committed to improving and restoring sight for patients worldwide. Since debuting the world’s first disposable soft contact lens in 1987, it has been helping patients see better through their world-leading ACUVUE® Brand Contact Lenses portfolio. In 2017, Johnson & Johnson invested further in eye health by expanding into cataract surgery, laser refractive surgery (LASIK), consumer eye health and the diagnosis and treatment of dry eye. Serving more than 60 million patients a day across 103 countries, Johnson & Johnson Vision is committed to helping more people in more places improve or restore their sight. Dual headquartered in Jacksonville, Florida, and Santa Ana, California, Johnson & Johnson Vision has more than 8,400 employees worldwide.